Bidding Dates
09 Feb 24 - 13 Feb 24
Price Range ₹
1195 - 1258
Total Equity
₹ 899.48Cr
Lot Size
11
Exchange Status
NSE,BSE
IPO Doc
Non-Institutional Investor
1.33×
Qualified Institutional Buyers
2.28×
Employees
1.25×
Retail Investors
1.33×
Total subscription Rate
1.53×
Offer start
09 Feb 2024
Offer end
13 Feb 2024
Allotment
14 Feb 2024
Refund initiation
15 Feb 2024
Demat transfer
15 Feb 2024
Listing
16 Feb 2024
Offer start
09 Feb 2024
Offer end
13 Feb 2024
Allotment
14 Feb 2024
Refund initiation
15 Feb 2024
Demat transfer
15 Feb 2024
Listing
16 Feb 2024
Incorporated in 2018, Entero Healthcare Solutions Limited operates as a distributor of healthcare products in India. Leveraging a technology-driven platform, the company provides distribution services for healthcare products to pharmacies, hospitals, and clinics across India. Over the fiscal years 2021, 2022, and 2023, Entero Healthcare Solutions served an increasing number of retail customers, with figures reaching over 39,500, 64,200, and 81,400, respectively. Moreover, they expanded their services to hospital customers, catering to over 1,600, 2,500, and 3,400 hospitals during the same period. The company boasts relationships with more than 1,900 healthcare product manufacturers, granting them access to an extensive inventory comprising over 64,500 product stock-keeping units as of March 31, 2023.
Year Founded
10-01-2018
Promotor Details
Sujesh Vasudevan
Particular | Pre-IPO | Post-IPO |
---|---|---|
Percentage | 78.85 | 52.44 |
Share Capital | 12668193 | 22807166 |
71,50,100.00 Cr
Years | Total Assets | Share Capital | Profit After Tax | Consolidated Net Profit | Adjusted EPS |
---|---|---|---|---|---|
2023 | 13,067.19 | 6,677.26 | -111.04 | -115.57 | -28.1055 |
2021 | 8,334.58 | 5,172.12 | -153.54 | -155.37 | -1553.7 |
2022 | 11,253.06 | 6,228.40 | -294.39 | -299.20 | -77.7143 |